Holen Sie sich die Stockscreener-App
152.65
0.96%
1.45
Handel nachbörslich:
152.65
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten
Quest Diagnostics Incorporated (NYSE:DGX) Position Boosted by UMB Bank n.a. - MarketBeat
Short Interest in Quest Diagnostics Incorporated (NYSE:DGX) Increases By 6.3% - MarketBeat
9,488 Shares in Quest Diagnostics Incorporated (NYSE:DGX) Bought by Avanza Fonder AB - MarketBeat
DGX (Quest Diagnostics) Operating Income : $1,252 Mil (TTM As of Sep. 2024) - GuruFocus.com
Wedge Capital Management L L P NC Decreases Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Assenagon Asset Management S.A. Purchases 108,224 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Stock Position Raised by Occidental Asset Management LLC - MarketBeat
Miracle Mile Advisors LLC Takes $291,000 Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics (DGX) Stock Price, News & Analysis - MarketBeat
Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare - Yahoo Finance
Earnings Preview: What to Expect From Quest Diagnostics' Report - MSN
Revenue Cycle Management (RCM) Market Size is Expected to Reach USD 873.74 by 2033, Growing at a CAGR of 11%: Straits Research - GlobeNewswire Inc.
Sawyer & Company Inc Sells 2,168 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Gets Meta Data-Share Suit Tossed For Now - Law360
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Quest Diagnostics Wins Dismissal of Suit Over Meta Info Sharing - Bloomberg Law
Earnings Preview: What To Expect From Quest Diagnostics' Report - Barchart
Oak Thistle LLC Increases Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics (NYSE:DGX) Downgraded by StockNews.com to "Hold" - MarketBeat
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Clean Yield Group Purchases 3,983 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Relationship Genetic Tests Market Report 2024, Featuring - GlobeNewswire
Relationship Genetic Tests Market Report 2024, Featuring Profiles of Laboratory Corporation of America, Quest Diagnostics, Cleveland Clinic, Myriad Genetics, Invitae and More - Yahoo Finance
Zacks Research Has Bullish Outlook for DGX FY2025 Earnings - MarketBeat
Ex-Dividend Reminder: Universal Corp, Shoe Carnival and Quest Diagnostics - Nasdaq
Alzheimer's Disease Diagnostics Research Report 2024-2034: Global Market to Reach $27.87 Billion - GlobeNewswire Inc.
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Quest Diagnostics Employee Shares How Music Career Led to Healthcare Logistics Success - StockTitan
Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer - Financial Times
Nordea Investment Management AB Sells 13,456 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics (NYSE:DGX) Stock Rating Upgraded by Leerink Partnrs - MarketBeat
Quest Diagnostics Inc. stock rises Monday, still underperforms market - MarketWatch
Leerink Partners Upgrades Quest Diagnostics (DGX) - MSN
Quest Diagnostics (NYSE:DGX) Upgraded to "Outperform" at Leerink Partners - MarketBeat
Quest Diagnostics upgraded by Leerink Partners with a new price target - Quantisnow
Quest Diagnostics (NYSE:DGX) shareholders have earned a 9.4% CAGR over the last five years - Simply Wall St
Quest Diagnostics Inc. stock rises Friday, still underperforms market - MarketWatch
Why Quest Diagnostics (DGX) is Poised to Beat Earnings Estimates Again - Yahoo Finance
OhioHealth outsourcing some lab work to Quest Diagnostics - The Business Journals
Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025 - Longview News-Journal
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
Should You Hold Quest Diagnostics Stock in Your Portfolio Now? - MSN
How Is Quest Diagnostics' Stock Performance Compared to Other Diagnostics & Research Stocks? - MSN
How Is The Market Feeling About Quest Diagnostics? - Benzinga
Short Interest in Quest Diagnostics Incorporated (NYSE:DGX) Declines By 6.4% - MarketBeat
JPMorgan Chase & Co. Sells 18,505 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Lobbying Update: QUEST DIAGNOSTICS INCORPORATED just disclosed $80,000 of lobbying spending - Nasdaq
Quest Diagnostics Incorporated (NYSE:DGX) Receives $169.15 Average PT from Brokerages - MarketBeat
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Quest Diagnostics Inc. stock rises Tuesday, still underperforms market - MarketWatch
2.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):